logo
Why Recursion Pharmaceuticals, Inc. (RXRX) Surged On Friday?

Why Recursion Pharmaceuticals, Inc. (RXRX) Surged On Friday?

Yahoo12-04-2025

We recently published a list of . In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other Friday's top performing stocks.
The stock market finished the trading week on a positive note, wiping out earlier losses on Friday, as investors weighed the escalating trade tensions between the US and China.
Having been battered this week, Wall Street's major indices all finished in the green, led by the Nasdaq, up 2.06 percent, followed by the S&P 500 with 1.81 percent, and the Dow Jones with 1.56 percent.
Ten companies, predominantly under the mining and biopharmaceutical sectors, mimicked gains on the back of fresh industry catalysts that boosted buying appetite. In this article, let us explore Friday's top performers and the reasons behind their gains.
To come up with the list, we considered only the stocks with a $2 billion market capitalization and $5 million trading volume.
A pharmacist in a hospital pharmacy stands next to a row of various drug containers.
Recursion Pharmaceuticals soared by 27.72 percent on Friday to finish at $5.76 apiece as investors gobbled up shares in the company following the Food and Drug Administration's (FDA) decision to replace the use of animals in testing drugs with Artificial Intelligence.
RXRX is a clinical-stage biotechnology company that uses AI in its discovery and development processes. It was also one of the companies that received the backing of technology giant Nvidia Corp.
According to the FDA, the initiative was designed to replace animal testing with 'more effective human-relevant methods' in the development of monoclonal antibody therapies and other drugs.
The move was not only expected to improve drug safety and expedite the evaluation process, but it could also result in lower research and development costs, thereby reducing drug prices for the end consumers.
According to the FDA, it will begin to encourage the inclusion of New Approach Methodologies (NAMs) data in investigational new drug applications.
Overall, RXRX ranks 1st on our list of Friday's top performing stocks. While we acknowledge the potential of RXRX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is as promising as RXRX but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Krispy Kreme, Inc. Class Action: Levi & Korsinsky Reminds Krispy Kreme, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 15, 2025
Krispy Kreme, Inc. Class Action: Levi & Korsinsky Reminds Krispy Kreme, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 15, 2025

Business Upturn

time19 minutes ago

  • Business Upturn

Krispy Kreme, Inc. Class Action: Levi & Korsinsky Reminds Krispy Kreme, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 15, 2025

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Krispy Kreme, Inc. ('Krispy Kreme, Inc.' or the 'Company') (NASDAQ: DNUT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Krispy Kreme, Inc. investors who were adversely affected by alleged securities fraud between February 25, 2025 and May 7, 2025. Follow the link below to get more information and be contacted by a member of our team: Krispy Kreme, Inc. Lawsuit Submission Form DNUT investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) demand for Krispy Kreme products declined materially at McDonald's locations after the initial marketing launch; (2) demand at McDonald's locations was a driver of declining average sales per door per week; (3) the partnership with McDonald's was not profitable; (4) the foregoing posed a substantial risk to maintaining the partnership with McDonald's; (5) as a result, the Company would pause expansion into new McDonald's locations; and (6) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Krispy Kreme, Inc. during the relevant time frame, you have until July 15, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004 [email protected] Tel: (212) 363-7500Fax: (212) 363-7171

As Google AI Takes Over Search, News Sites Lose Clicks and Cut Jobs
As Google AI Takes Over Search, News Sites Lose Clicks and Cut Jobs

Yahoo

time22 minutes ago

  • Yahoo

As Google AI Takes Over Search, News Sites Lose Clicks and Cut Jobs

Google (NASDAQ:GOOG) is drawing criticism from media executives who say its growing use of artificial intelligence is reducing traffic to news outlets, forcing them to rethink their digital strategies and slash jobs. According to a Wall Street Journal report Tuesday, publishers are reporting major declines in referral traffic as Google's AI Overviews and chatbot features increasingly serve answers directly to users eliminating the need to click on search results. The shift from a search engine to an answer engine is real, said The Atlantic's CEO Nicholas Thompson, who added that media companies now have to explore new approaches to stay relevant. Data from analytics firm Similarweb, cited in the report, shows steep drops in organic search traffic across major publishers: HuffPost's desktop and mobile traffic more than halved in the past three years. The Washington Post saw nearly the same level of decline. Business Insider reported a 55% drop and recently laid off 21% of its workforce. The New York Times saw its share of organic search traffic shrink to 36.5% in April 2025, down from almost 44% in 2022. Although The Wall Street Journal's search traffic rose in raw numbers, its share of total traffic dipped to 24% from 29% over the same period. WaPo CEO William Lewis warned that click-free search answers represent a serious threat to journalism. Beyond news, Google's AI tools have also dented traffic to travel guides, health information, and product review pages. The report notes that Google's upcoming AI Mode could hit even harder. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

S&P 500 Just 2% From All-Time High as Beijing Talks Continue
S&P 500 Just 2% From All-Time High as Beijing Talks Continue

Yahoo

time27 minutes ago

  • Yahoo

S&P 500 Just 2% From All-Time High as Beijing Talks Continue

June 10 - The S&P 500 moved slightly higher Tuesday and now sits about 2% below its all-time high of 6,147.43, as investors watch the second day of U.S.-China trade negotiations unfold in London. Officials have yet to share firm outcomes, but U.S. Treasury Secretary Scott Bessent and Commerce Secretary Howard Lutnick both said initial talks were constructive, without disclosing specific progress. List of 52-Week Lows List of 3-Year Lows List of 5-Year Lows Export restrictions remain a central issue. The U.S. is reportedly pressing China to boost shipments of rare earth materials critical for semiconductors, smartphones, and EVs. In exchange, Washington may ease curbs on American exports of chipmaking gear, aircraft parts, and ethane, according to the Financial Times. Last year, U.S. goods exports to China totaled $143.22 billion, while imports reached $438.74 billion, leaving a trade gap of $295.51 billion. For 2025, the deficit is already $88.02 billion through April. Investors are watching closely, as the outcome of the talks could impact supply chains and global tech stocks. This article first appeared on GuruFocus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store